Here's the Deal
Baird's Investment Banking Group is pleased to announce the following transaction:
AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ-CM:AHCO) recently completed an underwritten public offering of 9,200,000 shares of its Class A Common Stock at a public offering price of $33.00 per share, including the underwriters’ option to purchase an additional 1,200,000 shares of common stock. The offering consists of 8,450,000 shares of Class A Common Stock sold by the Company and an additional 750,000 shares of the Company’s Class A Common Stock sold by selling stockholders. The Company intends to use approximately half of the net proceeds from the offering to finance the AeroCare acquisition and the remainder for general corporate purposes.
AdaptHealth is a leading provider of home healthcare equipment, medical supplies to the home and related services in the United States. AdaptHealth provides a full suite of medical products and solutions designed to help patients manage chronic conditions in the home, adapt to life and thrive. Product and services offerings include (i) sleep therapy equipment, supplies and related services to individuals suffering from obstructive sleep apnea, (ii) medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors and insulin pumps), (iii) home medical equipment (HME) to patients discharged from acute care and other facilities, (iv) oxygen and related chronic therapy services in the home and (v) other HME medical devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs. As of September 30, 2020, AdaptHealth services over approximately 1.8 million patients annually in all 50 states through its network of 269 locations in 41 states. The Company is headquartered in Plymouth Meeting, Pennsylvania.
For additional information about this transaction, please contact: